Potential cognitive effects of targeted drugs in children may be reversible with therapy

(American Association for Cancer Research) Young mice that received molecularly targeted therapies used to treat brain cancer in human patients sustained cognitive and behavioral deficits, but the deficits were largely reversible through environmental stimulation and physical exercise. The study suggests that pediatric brain cancer patients may experience similar side effects of molecularly targeted therapies, and may benefit from efforts to remediate any cognitive deficits.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news